Primary atrophic solitary morphea profunda

Dermatology

Volumn 217, Issue 3, 2008, Pages 207-210

  Khelifa, Elhem ^a   Masouyé, Isabelle ^a   Chavaz, Pierre ^a   Hauser, Herman ^b   Grillet, Jean Pierre ^c   Borradori, Luca ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LA TOUR HOSPITAL   (Switzerland)

^c NONE

Author keywords

Lipoatrophy; Morphea profunda; Scleroderma; Vaccination

Indexed keywords

COLLAGEN; DOXYCYCLINE; INFLUENZA VACCINE; STEROID;

ADULT; ANAMNESIS; ARTICLE; ATROPHIC SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; DELTOID MUSCLE; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INFLUENZA; LIPOATROPHY; MICROSCOPY; MORPHEA; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; SOLITARY MORPHEA PROFUNDA; SUBCUTANEOUS FAT;

FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SCLERODERMA, LOCALIZED;

EID: 53549105824     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000141959     Document Type: Article

References (26)

1. Dancey AL, Waters RA: Morphea of the breast: two case reports and discussion of the literature. J Plast Reconstr Aesthet Surg 2006;59:1114-1117.
2. Savoia P, Zaccagna A, Bernengo MG: Guess what? Inflammatory disseminated morphea profunda. Eur J Dermatol 1999;9:654-656.
3. Melani L, Cardinali C, Giomi B, Schincaglia E, Caproni M, Fabbri P: Case study: periodic follow-up is necessary in morphea profunda to identify systemic evolution. Skinmed 2005;4:188-190.
4. Whittaker SJ, Smith NP, Jones RR: Solitary morphoea profunda. Br J Dermatol 1989;120:431-440.
5. Buchner SA, Rufli T: Morphaea profunda. Hautarzt 1990;41:155-157.
6. Kirsner RS, Pardes JB, Falanga V: Solitary fibrosing paraspinal plaque: solitary morphoea profunda? Br J Dermatol 1993;128:99-101.
7. Ahn S, Won JH, Choi EH, et al: Perforating plate - like osteoma cutis in a man with solitary morphea profunda. Br J Dermatol 1996;134:949-952.
8. 3 expression in solitary morphoea profunda with histological membranocytic changes. Br J Dermatol 2002;146:171-173.
9. Azad J, Dawn G, Shaffrali FC, Holmes SC, Barnetson RJ, Forsyth A: Does solitary morphoea profunda progress? Clin Exp Dermatol 2004;29:25-27.
10. Blaszczyk M, Krysicka-Janiger K, Jablonska S: Primary atrophic profound linear scleroderma: report of three cases. Dermatology 2000;200:63-66.
11. Sayama K, Chen M, Shiraishi S: Morphea profunda. Int J Dermatol 1991;30:873-875.
12. Julian CG, Bowers PW: Osteoma cutis in a lesion of solitary morphoea profunda. Clin Exp Dermatol 2003;28:673-674.
13. Diseases of connective tissue;in Braun-Falco O, Plewig G, Wolff HH, Burgdorf W (eds): Dermatology. Berlin, Springer, 2002, pp 785-795.
14. Wojas-Pelc A, Wielowieyska-Szybinska D, Kieltyka A: Presence of the antinuclear antibodies and antibodies to Borrelia burgdorferi among patients with morphea en plaque, deep linear scleroderma and atrophoderma Pasini-Pierini. Przegl Lek 2002;59:898-902.
15. Torrelo A, Suarez J, Colmenero I, Azorin D, Perera A, Zambrano A: Deep morphea after vaccination in two young children. Pediatr Dermatol 2006;23:484-487.
16. Hehn J, Hartmann K, Bröcker EB, Goebeler M: Influenza-Schutzimpfung und Dermatosen - Koinzidenz oder kausale Assoziation? J Dtsch Dermatol Ges 2003;1:99-104.
17. Park JH, Lee CW: Concurrent development of dermatomyositis and morphoea profunda. Clin Exp Dermatol 2002;27:324-327.
18. Lupton GP, Goette DK: Localized eosinophilic fasciitis. Arch Dermatol 1979;115:85-87.
19. Kencka D, Blaszczyk M, Jablonska S: Atrophoderma Pasini-Pierini is a primary atrophic abortive morphea. Dermatology 1995;190:203-206.
20. Choffray A, Pinquier L, Bachelez H: Exacerbation of lupus panniculitis following antihepatitis-B vaccination. Dermatology 2007;215:152-154.
21. Yamamoto T, Yokozeki H, Nishioka K: Localized involutional lipoatrophy: report of six cases. J Dermatol 2002;29:638-643.
22. Dahl PR, Zalla MJ, Winkelmann RK: Localized involutional lipoatrophy: a clinicopathologic study of 16 patients. J Am Acad Dermatol 1996;35:523-528.
23. Sunderkotter C, Kuhn A, Hunzelmann N, Beissert S: Phototherapy: a promising treatment option for skin sclerosis in scleroderma? Rheumatology 2006;45(suppl 3):iii52-iii54.
24. Sawada H, Isogai Z, Morita A: Altered decorin expression of systemic sclerosis by UVA1 (340-400 nm) phototherapy: immunohistochemical analysis of 3 cases. BMC Dermatol 2003;3:2.
25. Quan T, He T, Kang S, Voorhees JJ, Fisher GJ: Connective tissue growth factor: expression in human skin in vivo and inhibition by ultraviolet irradiation. J Invest Dermatol 2002;18:402-408.
26. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M: Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997;350:1295-1296.